术后运动功能和处理速度作为慢性期质母细胞瘤患者生活质量的预测指标
Riho Nakajima1, Masashi Kinoshita2, Hirokazu Okita3
1Department of Occupational Therapy, Faculty of Health Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Acta neurochirurgica
|August 31, 2024
概括
质母细胞瘤患者经常经历生活质量 (QOL) 的降低. 这项研究发现,保持运动功能和处理速度是质母细胞瘤 (GBM) 幸存者更好的QOL的关键预测因素.
科学领域:
- 神经瘤学神经瘤学
- 生活质量研究 研究 生命质量研究
- 认知神经科学 认知神经科学
背景情况:
- 质母细胞瘤 (GBM) 是具有不良预后的侵袭性脑瘤,需要关注生存质量.
- 神经认知缺陷显著影响GBM患者的生活质量 (QOL).
- 之前的QOL研究依赖于自我报告的下降,这可能不准确地反映特定的功能障碍.
研究的目的:
- 客观地评估影响GBM患者QOL的神经认知功能.
- 确定特定的认知领域,预测GBM幸存者的QOL结果.
主要方法:
- 从手术后6个月的40名新诊断的GBM患者的数据分析.
- 使用36项简短形式调查 (SF-36) 对神经认知功能和质量生活的综合评估.
- 统计评估包括多重逻辑回归和千平方测试,以确定QOL分数 (PCS,MCS,RCS) 与神经认知功能之间的关联.
主要成果:
- 与健康对照组相比,GBM患者的身体成分总结 (PCS) 和角色和社会成分总结 (RCS) 得分明显较低.
- 运动功能与PCS有显著的相关性,处理速度与RCS有显著的相关性.
- 维持较高RCS或PCS得分的患者更有可能保持运动功能或处理速度.
结论:
- 运动功能和处理速度成为质母细胞瘤患者的QOL显著预测因素.
- 对这些神经认知功能的客观评估可以为提高GBM幸存者的生存质量的策略提供信息.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...